Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 13

Results For "ABI"

3261 News Found

Alembic receives tentative U.S. FDA approval for Dabigatran Etexilate capsules
Drug Approval | November 23, 2021

Alembic receives tentative U.S. FDA approval for Dabigatran Etexilate capsules

Dabigatran Etexilate capsules are indicated to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation, and for the treatment of deep venous thrombosis (DVT) and pulmonary embolism (PE)


Roche retains its sustainability ranking in the Dow Jones Sustainability Indices
Sustainability | November 15, 2021

Roche retains its sustainability ranking in the Dow Jones Sustainability Indices

The company performed particularly well in operational eco-efficiency, environmental and social reporting


AstraZeneca India launches solar project to achieve sustainability goals
Sustainability | October 11, 2021

AstraZeneca India launches solar project to achieve sustainability goals

The company will shift 100 percent of its energy use to renewable sources for both power and heat by 2025 in order to achieve carbon neutrality


Zuellig Pharma receives EcoVadis Platinum medal for sustainability
Sustainability | October 05, 2021

Zuellig Pharma receives EcoVadis Platinum medal for sustainability

The company's sustainability programme was evaluated on its policies, actions put in place to support objectives and targets, as well as results that were generated from the programme


Positive results from Lynparza with abiraterone delays Metastatic prostrate cancer
Drug Approval | September 28, 2021

Positive results from Lynparza with abiraterone delays Metastatic prostrate cancer

Prostate cancer is the second-most common cancer in men and despite an increase in the number of available treatments for men with mCRPC, five-year survival remains low


HUL funds study on Covid-19 vulnerability and vaccine efficiency
News | September 07, 2021

HUL funds study on Covid-19 vulnerability and vaccine efficiency

The study is being carried out by the platform VISION (Vaccine Immunology Studies – Indian Outbreak-response Network) which includes top public and private research institutes.


Accutest enables NMPA approval for Qilu’s Abiraterone
Drug Approval | September 06, 2021

Accutest enables NMPA approval for Qilu’s Abiraterone

The bioequivalence study was conducted by Accutest Research India, one of the preferred CRO players in India


Illumina donates US $ I million in sequencing capabilities to BMC in Mumbai
Healthcare | August 04, 2021

Illumina donates US $ I million in sequencing capabilities to BMC in Mumbai

It supports sequencing-based COVID 19 surveillance in India


Zydus Cadila receives USFDA approval for Emtricitabine and Tenofovir Disoproxil
News | July 04, 2021

Zydus Cadila receives USFDA approval for Emtricitabine and Tenofovir Disoproxil

The drug is used with other HIV medications to help control HIV infection and it helps to decrease the amount of HIV in one’s body so that the immune system can work better


Lupin Launches Emtricitabine and Tenofovir Disoproxil Fumarate Tablets in the US
News | June 27, 2021

Lupin Launches Emtricitabine and Tenofovir Disoproxil Fumarate Tablets in the US

It is also used for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection.